Alexander I. Spira, Karl Hsu, Stephanie Robertson, Celeste DiJohnson, Kathleen Roberge, Doug Baumann, Franklin Vairinhos, Zachary Bergeron, Ann Boija, Isaac Klein, David Sommerhalder. "An open-label, multicenter study of DPTX3186 to evaluate safety, tolerability, and pharmacokinetics in subjects with known Wnt pathway–activated solid tumors where no other treatments exist.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps3169